Thanks to the work of Fred Hutch/University of Washington clinical researchers, a big discovery may soon make a “big, big ...
Rucaparib maintenance therapy provided consistent benefits across all subgroups of patients grouped by prognostic factors of their homologous recombination deficiency-negative ovarian cancer tumors.
SAN DIEGO & SEOUL, South Korea--(BUSINESS WIRE)--Inocras, a bioinformatics-led company harnessing the power of whole-genome data and proprietary analytics to deliver curated insights, today announced ...
Human resources departments in large organizations often create specialized positions within the department as some HR employees focus on benefits planning, training, wellness, or another specific ...
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma Surrogate readouts of HRD identify a greater proportion of patients with ...
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP) Homologous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results